Tricyclics are cyclic chemical compounds that contain three fused rings of atoms.

Dibenzazepine
Phenothiazine

Many compounds have a tricyclic structure, but in pharmacology, the term has traditionally been reserved to describe heterocyclic drugs. They include antidepressants, antipsychotics, anticonvulsants, and antihistamines (as antiallergens, anti-motion sickness drugs, antipruritics, and hypnotics/sedatives) of the dibenzazepine, dibenzocycloheptene, dibenzothiazepine, dibenzothiepin, phenothiazine, and thioxanthene chemical classes, and others.

History edit

  • Promethazine and other first generation antihistamines with a tricyclic structure were discovered in the 1940s.
  • Chlorpromazine, derived from promethazine originally as a sedative, was found to have neuroleptic properties in the early 1950s, and was the first typical antipsychotic.
  • Imipramine, originally investigated as an antipsychotic, was discovered in the early 1950s, and was the first tricyclic antidepressant.
  • Carbamazepine was discovered in 1953, and was subsequently introduced as an anticonvulsant in 1965.
  • Clozapine, a derivative of imipramine, was synthesized in 1958 and entered the European market in 1972 under the name Leponex.
  • Antidepressants with a tetracyclic structure such as mianserin and maprotiline were first developed in the 1970s as tetracyclic antidepressants.
  • Loratadine was introduced as a non-sedating second generation antihistamine in the 1990s.[1]

Gallery edit

Antidepressants
 

Imipramine

 

Amitriptyline

 

Iprindole

 

Tianeptine

 

Doxepin

Antipsychotics
 

Chlorpromazine

 

Thioridazine

 

Chlorprothixene

 

Loxapine

 

Clozapine

Antihistamines
 

Promethazine

 

Cyproheptadine

 

Latrepirdine

 

Loratadine

 

Rupatadine

Others
 

Carbamazepine

 

Carvedilol

 

Cyclobenzaprine

 

Pizotifen

See also edit

References edit

  1. ^ Kay, G. G.; Harris, A. G. (1999). "Loratadine: a non-sedating antihistamine. Review of its effects on cognition, psychomotor performance, mood and sedation". Clinical and Experimental Allergy. 29 Suppl 3: 147–150. doi:10.1046/j.1365-2222.1999.0290s3147.x. PMID 10444229.